Zimmer Biomet Holdings Inc banner

Zimmer Biomet Holdings Inc
XMUN:ZIM

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
XMUN:ZIM
Watchlist
Price: 79.97 EUR 0.46% Market Closed
Market Cap: €16.5B

Wall St Price Targets

ZIM Price Targets Summary
Zimmer Biomet Holdings Inc

Wall Street analysts forecast ZIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZIM is 86.12 EUR with a low forecast of 71.59 EUR and a high forecast of 115.77 EUR.

Lowest Forecast
Price Target
71.59 EUR
10% Downside
Average Forecast
Price Target
86.12 EUR
8% Upside
Highest Forecast
Price Target
115.77 EUR
45% Upside
Zimmer Biomet Holdings Inc Competitors:
Price Targets
PXS
Pyxis Tankers Inc
131% Upside

Revenue
Forecast

4% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
4% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

4% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
4% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

2% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-35%
Average Miss
2% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-35%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 22%.

Pre-Tax Income
Forecast

-1% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-53%
Average Miss
-1% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-53%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 40%.

Net Income
Forecast

-1% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss
-1% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 38%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ZIM's stock price target?
Price Target
86.12 EUR

According to Wall Street analysts, the average 1-year price target for ZIM is 86.12 EUR with a low forecast of 71.59 EUR and a high forecast of 115.77 EUR.

What is the Revenue forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
4%

Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 22%.

What is the Pre-Tax Income forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
40%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 40%.

What is the Net Income forecast for Zimmer Biomet Holdings Inc?
Projected CAGR
38%

Over the last 14 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 38%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett